News

Low vitamin D is found to double risk of CVD death

27-Jun-08

Better surveillance of vitamin D needed to detect those at high risk.

GPs should measure vitamin D frequently in high-risk patients, as low levels of the sunshine vitamin can double the risk of death from cardiovascular disease (CVD), say Austrian researchers.

The study involved 3,258 men and women, aged an average of 62 years. In all, 2.4 per cent of patients reported taking vitamin D supplements.

Fasting venous blood samples were taken from each partici-pant for 12 consecutive months to calculate average serum levels of the active version of vitamin D. Based on these findings, participants were divided into four groups.

Those in the lowest group had an average vitamin D level of 7.6ng/ml, compared with 28.4ng/ml for those in the highest quartile of vitamin D levels.

Participants were followed up for seven years, during which time 737 patients died, 62.8 per cent of them due to CVD.

Patients in the lowest vitamin D intake group were 2.08 times more likely to die from any cause and 2.2 times more likely to die from CVD than patients in the highest vitamin D group.

High levels of inflammatory marker C-reactive protein were also observed in those with the lowest vitamin D levels.

Lead researcher Dr Harald Dobnig, from the University of Graz, said high vitamin D levels may prevent death by lowering the risk of atherosclerosis but warned it was impossible to attribute the effects of vitamin D to one or two mechanisms.

'These results should prompt us to perform vitamin D measurements on a more frequent basis, especially in populations at high risk,' he said.

A 'generous approach' to vitamin D supplementation should be adopted, added Dr Dobnig.

sanjay.tanday@haymarket.com

Arch Intern Med 2008; 168: 1,340-8.

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

nMRCGP exam update - Evidence for aspirin use

Contributed by Dr Louise Newson, a GP in the West Midlands. Read more

RCGP curriculum - Introducing the GP curriculum

Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more

Alcohol problems in young people

Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more

Show all articles

 

Latest Clinical Articles

Altitude-related illness

Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more

Clinical Review - Subfertility in women

Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more

Stable angina pectoris

Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more

Show all clinical articles

MIMS Product News

Relistor

New drug - Relistor

Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more

Thalidomide available in the UK

Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more

MMR catch-up programme

The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more

Jobs

 

Job of the Week